These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2555874)

  • 41. The role of platelet-activating factor in the mammalian female reproductive tract.
    Tiemann U
    Reprod Domest Anim; 2008 Dec; 43(6):647-55. PubMed ID: 18363604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions. Contribution of PAF-releasing factor in serum.
    Miwa M; Sugatani J; Ikemura T; Okamoto Y; Ino M; Saito K; Suzuki Y; Matsumoto M
    J Immunol; 1992 Feb; 148(3):872-80. PubMed ID: 1730879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of platelet-activating factor (PAF) in immune and cytotoxic processes.
    Mencia-Hurerta JM; Pignol B; Paubert-Braquet M; Braquet P
    Prog Clin Biol Res; 1989; 308():441-6. PubMed ID: 2675061
    [No Abstract]   [Full Text] [Related]  

  • 44. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
    Stahl GL; Bitterman H; Lefer AM
    Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
    Arimura A; Harada M
    Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes of prostaglandin D2,carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock].
    Yang K; Guo XJ; Yan XB; Gao CR
    Fa Yi Xue Za Zhi; 2012 Jun; 28(3):175-8. PubMed ID: 22812216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
    Stewart AG; Harris T; De Nichilo M; Lopez AF
    Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells.
    Nasu K; Narahara H; Matsui N; Kawano Y; Tanaka Y; Miyakawa I
    Mol Hum Reprod; 1999 Jun; 5(6):548-53. PubMed ID: 10341002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC; Szpejda M
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis.
    Johnson CD
    Dig Surg; 1999; 16(2):93-101. PubMed ID: 10207233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells.
    Rodríguez M; Márquez S; Montero O; Alonso S; Frade JG; Crespo MS; Fernández N
    Biochem Pharmacol; 2016 Feb; 102():78-96. PubMed ID: 26673542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Inflammation; 2008 Apr; 31(2):112-20. PubMed ID: 18193345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet-activating factor antagonists in experimental shock.
    Muacevic G; Heuer HO
    Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of platelet activating factor in allergic inflammation.
    Spina D; Coyle AJ; Page CP
    Pulm Pharmacol; 1989; 2(1):13-9. PubMed ID: 2520484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet-activating factor--key mediator in neuroinjury?
    Frerichs KU; Feuerstein GZ
    Cerebrovasc Brain Metab Rev; 1990; 2(2):148-60. PubMed ID: 2201347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The metabolic effects of platelet-activating factor antagonism in endotoxemic man.
    Thompson WA; Coyle S; Van Zee K; Oldenburg H; Trousdale R; Rogy M; Felsen D; Moldawer L; Lowry SF
    Arch Surg; 1994 Jan; 129(1):72-9. PubMed ID: 8279943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological response of guinea pig peritoneal macrophages to platelet-activating factor.
    Hayashi H; Kudo I; Nojima S; Inoue K
    Lipids; 1991 Dec; 26(12):1193-9. PubMed ID: 1668117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock.
    Mózes T; Braquet P; Filep J
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R872-7. PubMed ID: 2802004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.